Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.07 Million ≈ $-2.21 Million USD) by net assets (CN¥1.74 Billion ≈ $254.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jiangsu Lianhuan Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Jiangsu Lianhuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Jiangsu Lianhuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Lianhuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Lianhuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Anhui Deli Household Glass Co Ltd
SHE:002571
-0.026x
Zhejiang Shengyang Science
SHG:603703
0.010x
Latitude Group Holdings Ltd
AU:LFS
-0.057x
Patrizia AG
XETRA:PAT
0.038x
Zheshang Development Group Co Ltd
SHE:000906
-0.164x
Jiujiang Shanshui Technology Co.Ltd
SHE:301190
-0.002x
Sinovac Biotech Ltd
NASDAQ:SVA
0.023x
China Building Material
SHG:603060
0.043x

Annual Cash Flow Conversion Efficiency for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. View 600513 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.58 Billion
≈ $230.80 Million
CN¥10.77 Million
≈ $1.58 Million
0.007x -93.56%
2023-12-31 CN¥1.52 Billion
≈ $222.03 Million
CN¥160.70 Million
≈ $23.52 Million
0.106x +17.35%
2022-12-31 CN¥1.41 Billion
≈ $206.87 Million
CN¥127.59 Million
≈ $18.67 Million
0.090x -16.44%
2021-12-31 CN¥1.28 Billion
≈ $187.44 Million
CN¥138.34 Million
≈ $20.24 Million
0.108x +38.86%
2020-12-31 CN¥1.18 Billion
≈ $172.97 Million
CN¥91.94 Million
≈ $13.45 Million
0.078x +954.26%
2019-12-31 CN¥1.08 Billion
≈ $158.63 Million
CN¥-9.87 Million
≈ $-1.44 Million
-0.009x +90.63%
2018-12-31 CN¥946.61 Million
≈ $138.52 Million
CN¥-92.00 Million
≈ $-13.46 Million
-0.097x -2447.48%
2017-12-31 CN¥878.23 Million
≈ $128.51 Million
CN¥3.64 Million
≈ $532.06K
0.004x -95.13%
2016-12-31 CN¥827.25 Million
≈ $121.05 Million
CN¥70.28 Million
≈ $10.28 Million
0.085x +5.99%
2015-12-31 CN¥774.88 Million
≈ $113.39 Million
CN¥62.12 Million
≈ $9.09 Million
0.080x -49.91%
2014-12-31 CN¥434.25 Million
≈ $63.54 Million
CN¥69.50 Million
≈ $10.17 Million
0.160x +73.13%
2013-12-31 CN¥402.11 Million
≈ $58.84 Million
CN¥37.17 Million
≈ $5.44 Million
0.092x +91.22%
2012-12-31 CN¥350.42 Million
≈ $51.28 Million
CN¥16.94 Million
≈ $2.48 Million
0.048x -34.00%
2011-12-31 CN¥327.61 Million
≈ $47.94 Million
CN¥24.00 Million
≈ $3.51 Million
0.073x +168.56%
2010-12-31 CN¥308.95 Million
≈ $45.21 Million
CN¥8.43 Million
≈ $1.23 Million
0.027x -42.05%
2009-12-31 CN¥293.89 Million
≈ $43.01 Million
CN¥13.83 Million
≈ $2.02 Million
0.047x -23.99%
2008-12-31 CN¥281.68 Million
≈ $41.22 Million
CN¥17.44 Million
≈ $2.55 Million
0.062x +108.09%
2007-12-31 CN¥269.97 Million
≈ $39.51 Million
CN¥8.03 Million
≈ $1.18 Million
0.030x -23.97%
2006-12-31 CN¥259.20 Million
≈ $37.93 Million
CN¥10.14 Million
≈ $1.48 Million
0.039x +162.08%
2005-12-31 CN¥255.97 Million
≈ $37.46 Million
CN¥3.82 Million
≈ $559.35K
0.015x +10.21%
2004-12-31 CN¥250.42 Million
≈ $36.64 Million
CN¥3.39 Million
≈ $496.50K
0.014x +125.29%
2003-12-31 CN¥246.22 Million
≈ $36.03 Million
CN¥-13.19 Million
≈ $-1.93 Million
-0.054x -123.77%
2002-12-31 CN¥85.26 Million
≈ $12.48 Million
CN¥19.22 Million
≈ $2.81 Million
0.225x --

About Jiangsu Lianhuan Pharmaceutical Co Ltd

SHG:600513 China Drug Manufacturers - Specialty & Generic
Market Cap
$642.86 Million
CN¥4.39 Billion CNY
Market Cap Rank
#11120 Global
#3124 in China
Share Price
CN¥15.39
Change (1 day)
+0.07%
52-Week Range
CN¥14.08 - CN¥30.75
All Time High
CN¥30.75
About

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprili… Read more